LONDON--(BUSINESS WIRE)--The global autologous cell therapy market is poised to grow by USD 1.97 billion during 2020-2024, progressing at a CAGR of almost 22% during the forecast period. Request free sample pages
Read the 120-page report with TOC on "Autologous Cell Therapy Market Analysis Report by Therapy (Autologous stem cell therapy and Autologous cellular immunotherapies), Application (Oncology, Musculoskeletal disorders, and Dermatology), Geography (North America, APAC, Europe, South America, and MEA), and the Segment Forecasts, 2020-2024".
The market is driven by the increasing demand for effective drugs for cardiac and degenerative disorders. In addition, the limitations in traditional organ transplantations are fueling the demand for stem cell therapies. All these factors are anticipated to boost the growth of the autologous cell therapy market.
The demand for effective drugs for cardiac and degenerative disorders has been increasing across the world. In addition, the discovery of possible cardiac autologous cells has enabled vendors to develop novel drugs for the treatment of various cardiac diseases. For instance, Mesoblast is developing MPC-150-IM. It is a Phase III candidate for the treatment of advanced and end-stage chronic heart failure. Similarly, Shire has been developing autologous stem cell therapies for chronic myocardial ischemia. These products are expected to be launched during the forecast period and will have a positive impact on the growth of the global autologous cell therapy market.
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
View market snapshot before purchasing
Major Five Autologous Cell Therapy Market Companies:
Bayer AG operates its business through segments such as Pharmaceuticals, Crop Science, Consumer Health, and Animal Health. The company offers induced pluripotent stem cells. They are developed by reprogramming mature body cells to behave like embryonic stem cells that are injected to restore diseased tissue in patients.
Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc. operates its business through an unified business segment. NurOwn is the key offering of the company. It is a cell therapy platform, which develops mesenchymal stem cells for the treatment of human diseases such as immune and inflammatory diseases.
Daiichi Sankyo Co. Ltd.
Daiichi Sankyo Co. Ltd. operates its business through segments such as Innovative Pharmaceuticals, Generic, Vaccine, and OTC Related. Heartcel is the key offering of the company. It is an immune-modulatory progenitor cell therapeutic agent, which is used for ischemic heart failure.
FUJIFILM Holdings Corp.
FUJIFILM Holdings Corp. operates its business through segments such as Imaging solutions, Healthcare and material solutions, and Document solutions. The company uses induced pluripotent stem cells to derive differentiated cells, which are used in researching various diseases and conditions.
Holostem Terapie Avanzate Srl
Holostem Terapie Avanzate Srl operates its business through an unified business segment. Holoclar is the key offering of the company. It is an advanced therapy medicinal product containing stem cells indicated to repair the cornea after injury.
Register for a free trial today and gain instant access to 17,000+ market research reports.
Technavio's SUBSCRIPTION platform
Autologous Cell Therapy Market Therapy Outlook (Revenue, USD Billion, 2020-2024)
Autologous Cell Therapy Market Application Outlook (Revenue, USD Billion, 2020-2024)
Autologous Cell Therapy Market Regional Outlook (Revenue, USD Billion, 2020-2024)
Technavios sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more.
Request a free sample report
Related Reports on Healthcare Include:
Global Cancer Stem Cell Therapeutics Market Global cancer stem cell therapy market by type (allogeneic stem cell transplant and autologous stem cell transplant) and geography (Asia, Europe, North America, and ROW).
Global Mantle Cell Lymphoma Therapeutics Market Global mantle cell lymphoma therapeutics market by product (combination therapy and monotherapy) and geography (Asia, Europe, North America, and ROW).
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
- Mesoblast : 3 Articles on RYONCIL GvHD Trial Results Published in BBMT - Marketscreener.com - May 25th, 2020
- Will there still be massage treatments? What the future of luxury spas looks like - Telegraph.co.uk - May 25th, 2020
- The Week Ahead In Biotech: ASCO Presentations In The Spotlight - Benzinga - May 25th, 2020
- Lawyer celebrates 40 years with Blythe Liggins after first day hiccup - Leamington Observer - May 24th, 2020
- Stem Cell Banking Market Market Share, Size 2020| Emerging Rapidly with Global Latest Trends, Growth, Revenue, Demand and Forecast to 2027 - Cole of... - May 24th, 2020
- Covid-19 Impact on Cancer Stem Cell Therapy Market Trends Analysis, Top Manufacturers, Shares, Growth Opportunities, Statistics & Forecast to 2026... - May 24th, 2020
- What is a cytokine storm? And why is its prevention key to treating Covid-19? - Scroll.in - May 24th, 2020
- Covid-19 Impact On Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market 2020 : Industry Trends, Size, Growth, Swot Analysis By Top Key... - May 24th, 2020
- Restoring vision to the blind - Science Magazine - May 24th, 2020
- Ontario Announces First Phase of Research Projects to Fight COVID-19 - Government of Ontario News - May 24th, 2020
- Umbilical Cord Stem Cell Therapy to Be Assessed in Severe COVID-19 - Pulmonology Advisor - May 23rd, 2020
- World coronavirus Dispatch: Animal Stem Cell Therapy Market Size, Share, Statistics, Demand and Revenue; Forecast To 2025 - 3rd Watch News - May 23rd, 2020
- Cells for Cells and Austrianova announce publication on novel method to produce stem cell exosomes - BioSpace - May 23rd, 2020
- The Economic Impact of Coronavirus on Platelet Rich Plasma and Stem Cell Alopecia Treatment Market : In-depth study on Industry Size and Analysis on... - May 23rd, 2020
- World coronavirus Dispatch: Rheumatoid Arthritis Stem Cell Therapy market to witness robust revenue growth between 2018 to 2028 - Cole of Duty - May 23rd, 2020
- Blocking the deadly cytokine storm is a vital weapon for treating COVID-19 - TheStreet - May 23rd, 2020
- Animal Stem Cell Therapy Market: Overview, Opportunities, Analysis of Features, Benefits, Manufacturing Cost and Forecast To 2025 - Cole of Duty - May 23rd, 2020
- Looking toward the Future of Cell & Gene Therapies - Genetic Engineering & Biotechnology News - May 22nd, 2020
- NantKwest Announces FDA Authorization of IND Application for Mesenchymal Stem Cell Product for the Treatment of Severe COVID-19 Patients - Yahoo... - May 22nd, 2020
- Kleo Pharmaceuticals and Celularity Enter into Research Collaboration to Rapidly Develop Allogeneic NK Cell Combination Therapies for COVID-19 and... - May 22nd, 2020
- Blocking the deadly cytokine storm is a vital weapon for treating COVID-19 - The Conversation US - May 22nd, 2020
- Analysis on Impact of COVID-19-Stem Cell Therapy Market 2020-2024 | Increase in Awareness of Stem Cell Therapy to Boost Growth | Technavio - Business... - May 19th, 2020
- NantKwest Announces FDA Authorization of IND Application for Mesenchymal Stem Cell Product for the Treatment of Severe COVID-19 Patients - Business... - May 19th, 2020
- Stem Cell Therapy Improved Quality of Life in Patients with Microvascular Dysfunction - Diagnostic and Interventional Cardiology - May 19th, 2020
- Can stem cell therapy help - Greater Kashmir - May 19th, 2020
- Family needs to raise 40k towards potentially life-changing treatment for mum with MS - Coventry Telegraph - May 19th, 2020
- Interim Results of Phase I Study Confirms Safety with Early Signs of Efficacy for TRPH-222 in NHL - OncoZine - May 19th, 2020
- Stem Cell Treatments Market Report, History and Forecast 2015-2025, Breakdown Data by Manufacturers, Key Regions, Types and Application - Express... - May 19th, 2020
- Umbilical Cord Stem Cell Therapy to Be Assessed in Severe COVID-19 - Monthly Prescribing Reference - May 17th, 2020
- Coronavirus: Emirati dentist who received stem cell therapy doing well - Gulf News - May 17th, 2020
- Stem Cell Therapy Market Research Report 2020 By Size, Share, Trends, Analysis and Forecast to 2026 - Cole of Duty - May 17th, 2020
- Outcomes of Hematopoietic Stem Cell Transplantation in Children With Diamond-Blackfan Anemia - Hematology Advisor - May 17th, 2020
- Venetoclax May Play Role as Salvage Therapy in Multiply Relapsed MCL - Targeted Oncology - May 17th, 2020
- The Week Ahead In Biotech: Aquestive Awaits FDA Decision, Earnings Flow Slows - Benzinga - May 17th, 2020
- GEMoaB Announces Data Presentations Supporting Key Features of Its UniCAR Platform At the Upcoming American Association for Cancer Research (AACR)... - May 17th, 2020
- Michael Hiltzik: Don't be taken in by stem cell firms offering unsubstantiated therapies for COVID-19 - Rome News-Tribune - May 15th, 2020
- Mike Tyson lifts lid on training regime and stem-cell therapy ahead of comeback - Metro.co.uk - May 15th, 2020
- Global Stem Cell Partnering Terms and Agreements 2010-2020 - ResearchAndMarkets.com - Business Wire - May 15th, 2020
- Mum's brutal stem cell treatment has 'all been worth it' as she enjoys time with family - Grimsby Live - May 15th, 2020
- Kleo Pharmaceuticals to Present Preclinical Data Highlighting the Synergistic Potential of Kleo Asset KP1237 and Autologous NK Cells in the Treatment... - May 15th, 2020
- Here's Why Big Buyers Are Excited About This Cancer Immunotherapy Stock - Motley Fool - May 15th, 2020
- Cost-Effectiveness Analysis of Tisagenlecleucel in the Treatment of Re | CEOR - Dove Medical Press - May 15th, 2020
- Mesoblast raises $138m from investors on hopes for COVID-19 treatment - Sydney Morning Herald - May 15th, 2020
- Group of Genes Have Altered Expression in Autism - Technology Networks - May 15th, 2020
- SENECA BIOPHARMA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q) - marketscreener.com - May 15th, 2020
- Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Growth by Top Companies, Trends by Types and Application, Forecast to 2026 - Cole of Duty - May 15th, 2020
- Cardio Stem Cell Therapy Used to Treat Critically Ill Covid-19 Patients - Physician's Weekly - May 14th, 2020
- Cellectar Granted Composition of Matter and Use Patent in Europe for CLR 131 - GlobeNewswire - May 14th, 2020
- Magenta Therapeutics Presents Data at Annual Meeting of American Society of Gene and Cell Therapy Demonstrating Cells Mobilized with MGTA-145 in a... - May 14th, 2020
- Scientists generate millions of nave human pluripotent stem cells, far more than have ever been produced - UB News Center - May 14th, 2020
- bluebird bio to Present Data from Its Gene and Cell Therapy Programs During the Virtual Edition of the 25th European Hematology Association Annual... - May 14th, 2020
- Regenerative Medicine Industry Outlook to 2025 Featuring Novartis, Vericel, Integra Lifesciences, Mimedx Group, Stryker, Wright Medical, Roche and... - May 14th, 2020
- Doctors just discovered another promising coronavirus therapy - BGR - May 14th, 2020
- Cell therapy firm boosts odds for blood cancer patients as key trial succeeds - The Times of Israel - May 14th, 2020
- Tiziana Life Sciences Announces Data Demonstrating StemPrintER's Superiority Compared to Oncotype DX in Providing Prognostic Information to... - May 14th, 2020
- Global Animal Stem Cell Therapy Market Types, Application, and Regions, Forecast 2020- 2025. :Global Globalmarketers.biz - Cole of Duty - May 14th, 2020
- FTC Letters Warn Marketers to Stop Making Unsupported Claims That Their Products and Therapies Can Effectively Prevent or Treat COVID-19 - New... - May 10th, 2020
- Autolus Therapeutics Plc (AUTL) Q1 2020 Earnings Call Transcript - The Motley Fool - May 10th, 2020
- Combating coronavirus: UAE announces its highest ever recoveries in a day - Khaleej Times - May 10th, 2020
- Orchard Therapeutics (ORTX) Q1 2020 Earnings Call Transcript - Motley Fool - May 10th, 2020
- Stem Cell Therapy Market To Boom In Near Future By 2027 Scrutinized In New Research - Cole of Duty - May 9th, 2020
- FDA approves Tabrecta, first targeted therapy to treat metastatic NSCLC - The Cancer Letter - May 9th, 2020
- FTC warns Oregon companies to stop claiming they can prevent or treat COVID-19 - KGW.com - May 9th, 2020
- Region 1: Chemotherapy, Part II - MedPage Today - May 9th, 2020
- World Thalassemia Day 2020: Causes, Symptoms, Diagnosis And Treatment of The Disease - India.com - May 9th, 2020
- Avrobio taps Magenta's ADC in ongoing quest to improve gene therapy conditioning - FierceBiotech - May 9th, 2020
- COVID-19: Responding to the business impacts of Rise in expanse of applications boosts Rheumatoid Arthritis Stem Cell Therapy market 2018 to 2028 3w... - May 9th, 2020
- Cell Therapy Market 2020 by Various Types, End-Use Application, Major Players, Forecast 2025 - Cole of Duty - May 9th, 2020
- Global Stem Cell Therapy Market 2020 With COVID-19 Update by Development factors analysis, Competitive Strategies and Forecast to 2025 - Bandera... - May 9th, 2020
- Stem Cell Treatment for COVID-19; Doctors Divided on Its Scope - The Quint - May 5th, 2020
- Mike Tyson, 53, reveals he had stem cell research therapy and hadnt hit bags for 15 YEARS before returning t - The Sun - May 5th, 2020
- Century Therapeutics Announces Formation of Scientific Advisory Board - Business Wire - May 5th, 2020
- Liberal MP Jim Carr to receive stem-cell transplant to treat blood cancer - The Globe and Mail - May 5th, 2020
- BioCardia Announces Positive Preclinical Results Supporting Investigational New Drug Application for Anti-Inflammatory Cell Therapy in Heart Failure -... - May 5th, 2020
- Canine Stem Cell Therapy Market To Extend An Assessed Value Of US$ 218.2 Mn By 2026 - Cole of Duty - May 5th, 2020
- Canine Stem Cell Therapy Market Analysis Of Growth, Trends Progress And Challenges Till Upcoming Year - Jewish Life News - May 5th, 2020
- Coronavirus Update: Baptist Hospital Patient Credits Stem Cell Treatment With Saving Her Life - CBS Miami - May 4th, 2020
- Stem cell treatment in the UAE sees 'favorable' outcomes for coronavirus patients - CNBC - May 4th, 2020
- Investigational new drug may be beneficial in treating severe COVID-19 - BioNews - May 4th, 2020
- Subcutaneous Formulation of Daratumumab Approved for Multiple Myeloma - Cancer Therapy Advisor - May 4th, 2020